APA (7th ed.) Citation

Basu, S., Lin, P., & Saha, V. (2017). PCN180 - The Cost-Effectiveness of Pegaspargase for First-Line Treatment of Acute Lymphoblastic Leukaemia: A Cost-Utility Analysis. Value in Health, 20(9), A444. https://doi.org/10.1016/j.jval.2017.08.263

Chicago Style (17th ed.) Citation

Basu, S., PL Lin, and V. Saha. "PCN180 - The Cost-Effectiveness of Pegaspargase for First-Line Treatment of Acute Lymphoblastic Leukaemia: A Cost-Utility Analysis." Value in Health 20, no. 9 (2017): A444. https://doi.org/10.1016/j.jval.2017.08.263.

MLA (9th ed.) Citation

Basu, S., et al. "PCN180 - The Cost-Effectiveness of Pegaspargase for First-Line Treatment of Acute Lymphoblastic Leukaemia: A Cost-Utility Analysis." Value in Health, vol. 20, no. 9, 2017, p. A444, https://doi.org/10.1016/j.jval.2017.08.263.